论文部分内容阅读
肿瘤患者出现贫血临床较为常见,且贫血程度往往与肿瘤的严重程度及患者的年龄呈正相关。目前,临床常用促红细胞生成素(EPO)治疗肿瘤性贫血,EPO能有效提高血红蛋白含量,缓解贫血程度,改善患者的生存质量。然而疗程较长,且随着治疗时间的增加幼红细胞对EPO的反应性也会降低。为提高疗效,笔者用中西医结合疗法,效果良好。1材料与方法1.1临床资料选2014年12月至2016年2月在本
Anemia in cancer patients is more common, and the degree of anemia is often positively correlated with the severity of the tumor and the patient’s age. At present, commonly used clinical erythropoietin (EPO) for the treatment of anemia, EPO can effectively improve the hemoglobin content, alleviate the degree of anemia and improve the quality of life of patients. However, longer course of treatment, and with the increase of treatment time erythroblast EPO reactivity will be reduced. In order to improve the curative effect, I use the combination therapy of Chinese and Western medicine, the effect is good. 1 Materials and Methods 1.1 clinical data selected December 2014 to February 2016 in this